ReviR Therapeutics is a global, clinical-stage biotechnology company committed to discovering and developing innovative RNA-targeting small-molecule therapies for neurological diseases, inflammation and immunology (I&I) and oncology. ReviR was founded in 2021 by leaders in computational biology, RNA biology, genomics and drug discovery, with the aim of creating highly selective, effective and safe disease-modifying therapies.
億世科技有限公司
With over 10 years of experience serving diverse industries and more than 80 solutions successfully deployed, we adopt an immersive and iterative…
英諾診斷有限公司
ImmunoDiagnostics Limited (IMD) is a spin-off biotechnology company which specialises in the research and development of research and diagnostic…
家健科技有限公司
Kin's mission is to accelerate the safety and convenience in personal healthcare at home. Kin Technology is founded in late 2018 by a group of…
We are a startup research and development company that develops novel early DNA methylation markers in blood for detecting cancers. Early detection…
HK Dtech. a spinoff company from Hong Kong Baptist University, specialises in in-vitro diagnostic and cell-imaging. We develop and manufacture…
Company Background Information: Established in 2011, Food Safety Technology Research Centre (FSTRC) is ambitious in establishing network among the…
